Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 137

1.

A new multiplex PCR protocol to detect mixed trypanosomatid infections in species of Apis and Bombus.

Bartolomé C, Buendía M, Benito M, De la Rúa P, Ornosa C, Martín-Hernández R, Higes M, Maside X.

J Invertebr Pathol. 2018 May;154:37-41. doi: 10.1016/j.jip.2018.03.015. Epub 2018 Mar 30.

PMID:
29608918
2.

Patient Engagement: The Fundació ACE Framework for Improving Recruitment and Retention in Alzheimer's Disease Research.

Boada M, Santos-Santos MA, Rodríguez-Gómez O, Alegret M, Cañabate P, Lafuente A, Abdelnour C, Buendía M, de Dios MJ, Morera A, Sanabria Á, Campo L, Ruiz A, Tárraga L.

J Alzheimers Dis. 2018;62(3):1079-1090. doi: 10.3233/JAD-170866.

3.

MicroRNA therapy inhibits hepatoblastoma growth in vivo by targeting β-catenin and Wnt signaling.

Indersie E, Lesjean S, Hooks KB, Sagliocco F, Ernault T, Cairo S, Merched-Sauvage M, Rullier A, Le Bail B, Taque S, Grotzer M, Branchereau S, Guettier C, Fabre M, Brugières L, Hagedorn M, Buendia MA, Grosset CF.

Hepatol Commun. 2017 Apr 6;1(2):168-183. doi: 10.1002/hep4.1029. eCollection 2017 Apr.

4.

Safety, tolerability and immunogenicity of an active anti-Aβ40 vaccine (ABvac40) in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase I trial.

Lacosta AM, Pascual-Lucas M, Pesini P, Casabona D, Pérez-Grijalba V, Marcos-Campos I, Sarasa L, Canudas J, Badi H, Monleón I, San-José I, Munuera J, Rodríguez-Gómez O, Abdelnour C, Lafuente A, Buendía M, Boada M, Tárraga L, Ruiz A, Sarasa M.

Alzheimers Res Ther. 2018 Jan 29;10(1):12. doi: 10.1186/s13195-018-0340-8.

5.

Longitudinal Neuroimaging Analysis in Mild-Moderate Alzheimer's Disease Patients Treated with Plasma Exchange with 5% Human Albumin.

Cuberas-Borrós G, Roca I, Boada M, Tárraga L, Hernández I, Buendia M, Rubio L, Torres G, Bittini Á, Guzmán-de-Villoria JA, Pujadas F, Torres M, Núñez L, Castell J, Páez A.

J Alzheimers Dis. 2018;61(1):321-332. doi: 10.3233/JAD-170693.

6.

New insights into diagnosis and therapeutic options for proliferative hepatoblastoma.

Hooks KB, Audoux J, Fazli H, Lesjean S, Ernault T, Dugot-Senant N, Leste-Lasserre T, Hagedorn M, Rousseau B, Danet C, Branchereau S, Brugières L, Taque S, Guettier C, Fabre M, Rullier A, Buendia MA, Commes T, Grosset CF, Raymond AA.

Hepatology. 2018 Jul;68(1):89-102. doi: 10.1002/hep.29672. Epub 2018 May 14.

PMID:
29152775
7.

Hepatitis B Virus Pregenomic RNA in Hepatocellular Carcinoma: A Nosological and Prognostic Determinant.

Halgand B, Desterke C, Rivière L, Fallot G, Sebagh M, Calderaro J, Bioulac-Sage P, Neuveut C, Buendia MA, Samuel D, Féray C.

Hepatology. 2018 Jan;67(1):86-96. doi: 10.1002/hep.29463.

PMID:
28802063
8.

Molecular classification of hepatoblastoma and prognostic value of the HB 16-gene signature.

Buendia MA, Armengol C, Cairo S.

Hepatology. 2017 Oct;66(4):1351-1352. doi: 10.1002/hep.29262. Epub 2017 Aug 26. No abstract available.

PMID:
28510309
9.

Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype.

Espinosa A, Alegret M, Pesini P, Valero S, Lafuente A, Buendía M, San José I, Ibarria M, Tejero MA, Giménez J, Ruiz S, Hernández I, Pujadas F, Martínez-Lage P, Munuera J, Arbizu J, Tárraga L, Hendrix SB, Ruiz A, Becker JT, Landau SM, Sotolongo-Grau O, Sarasa M, Boada M; AB255 Study Group; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2017;57(2):447-459. doi: 10.3233/JAD-161223.

10.

LIM-Only Protein FHL2 Is a Negative Regulator of Transforming Growth Factor β1 Expression.

Dahan J, Levillayer F, Xia T, Nouët Y, Werts C, Fanton d'Andon M, Adib-Conquy M, Cassard-Doulcier AM, Khanna V, Chen J, Tordjmann T, Buendia MA, Jouvion G, Wei Y.

Mol Cell Biol. 2017 May 2;37(10). pii: e00636-16. doi: 10.1128/MCB.00636-16. Print 2017 May 15.

11.

Efficacy and Safety of Plasma Exchange with 5% Albumin to Modify Cerebrospinal Fluid and Plasma Amyloid-β Concentrations and Cognition Outcomes in Alzheimer's Disease Patients: A Multicenter, Randomized, Controlled Clinical Trial.

Boada M, Anaya F, Ortiz P, Olazarán J, Shua-Haim JR, Obisesan TO, Hernández I, Muñoz J, Buendia M, Alegret M, Lafuente A, Tárraga L, Núñez L, Torres M, Grifols JR, Ferrer I, Lopez OL, Páez A.

J Alzheimers Dis. 2017;56(1):129-143. doi: 10.3233/JAD-160565.

12.

Combined Treatments with a Retinoid Receptor Agonist and Epigenetic Modulators in Human Neuroblastoma Cells.

Almeida VR, Vieira IA, Buendia M, Brunetto AT, Gregianin LJ, Brunetto AL, Klamt F, de Farias CB, Abujamra AL, Lopez PLDC, Roesler R.

Mol Neurobiol. 2017 Dec;54(10):7610-7619. doi: 10.1007/s12035-016-0250-3. Epub 2016 Nov 10.

PMID:
27832522
13.

Single-Nucleotide Resolution Mapping of Hepatitis B Virus Promoters in Infected Human Livers and Hepatocellular Carcinoma.

Altinel K, Hashimoto K, Wei Y, Neuveut C, Gupta I, Suzuki AM, Dos Santos A, Moreau P, Xia T, Kojima S, Kato S, Takikawa Y, Hidaka I, Shimizu M, Matsuura T, Tsubota A, Ikeda H, Nagoshi S, Suzuki H, Michel ML, Samuel D, Buendia MA, Faivre J, Carninci P.

J Virol. 2016 Nov 14;90(23):10811-10822. Print 2016 Dec 1.

14.

Targeting tyrosine receptor kinase B in gliomas.

Pinheiro KV, Alves C, Buendia M, Gil MS, Thomaz A, Schwartsmann G, de Farias CB, Roesler R, Bowman RL, Wang Q, Carro A, Verhaak RG, Squatrito M.

Neuro Oncol. 2017 Jan;19(1):138-139. doi: 10.1093/neuonc/now199. Epub 2016 Sep 14. No abstract available.

15.

The chronic obstructive pulmonary disease assessment test improves the predictive value of previous exacerbations for poor outcomes in COPD.

Miravitlles M, García-Sidro P, Fernández-Nistal A, Buendía MJ, Espinosa de Los Monteros MJ, Esquinas C, Molina J.

Int J Chron Obstruct Pulmon Dis. 2015 Nov 30;10:2571-9. doi: 10.2147/COPD.S91163. eCollection 2015.

16.

BDNF/TrkB Signaling as a Potential Novel Target in Pediatric Brain Tumors: Anticancer Activity of Selective TrkB Inhibition in Medulloblastoma Cells.

Thomaz A, Jaeger M, Buendia M, Bambini-Junior V, Gregianin LJ, Brunetto AL, Brunetto AT, de Farias CB, Roesler R.

J Mol Neurosci. 2016 Jul;59(3):326-33. doi: 10.1007/s12031-015-0689-0. Epub 2015 Nov 27.

PMID:
26614346
17.

CAGE profiling of ncRNAs in hepatocellular carcinoma reveals widespread activation of retroviral LTR promoters in virus-induced tumors.

Hashimoto K, Suzuki AM, Dos Santos A, Desterke C, Collino A, Ghisletti S, Braun E, Bonetti A, Fort A, Qin XY, Radaelli E, Kaczkowski B, Forrest AR, Kojima S, Samuel D, Natoli G, Buendia MA, Faivre J, Carninci P.

Genome Res. 2015 Dec;25(12):1812-24. doi: 10.1101/gr.191031.115. Epub 2015 Oct 28.

18.

HBx relieves chromatin-mediated transcriptional repression of hepatitis B viral cccDNA involving SETDB1 histone methyltransferase.

Rivière L, Gerossier L, Ducroux A, Dion S, Deng Q, Michel ML, Buendia MA, Hantz O, Neuveut C.

J Hepatol. 2015 Nov;63(5):1093-102. doi: 10.1016/j.jhep.2015.06.023. Epub 2015 Jul 2.

PMID:
26143443
19.

Corrigendum: Massive gene amplification drives paediatric hepatocellular carcinoma caused by bile salt export pump deficiency.

Iannelli F, Collino A, Sinha S, Radaelli E, Nicoli P, D'Antiga L, Sonzogni A, Faivre J, Buendia MA, Sturm E, Thompson RJ, Knisely AS, Natoli G, Ghisletti S, Ciccarelli FD.

Nat Commun. 2015 Jul 2;6:7456. doi: 10.1038/ncomms8456. No abstract available.

PMID:
26135945
20.

Deletion of Gαq in the telencephalon alters specific neurobehavioral outcomes.

Graham DL, Buendia MA, Chapman MA, Durai HH, Stanwood GD.

Synapse. 2015 Sep;69(9):434-45. doi: 10.1002/syn.21830. Epub 2015 Jun 3.

21.

Hepatocellular carcinoma.

Buendia MA, Neuveut C.

Cold Spring Harb Perspect Med. 2015 Feb 2;5(2):a021444. doi: 10.1101/cshperspect.a021444. Review.

22.

Association between cell-bound blood amyloid-β(1-40) levels and hippocampus volume.

Sotolongo-Grau O, Pesini P, Valero S, Lafuente A, Buendía M, Pérez-Grijalba V, José IS, Ibarria M, Tejero MA, Giménez J, Hernández I, Tárraga L, Ruiz A, Boada M, Sarasa M.

Alzheimers Res Ther. 2014 Oct 20;6(5-8):56. doi: 10.1186/s13195-014-0056-3. eCollection 2014.

23.

Unravelling the genetics of hepatoblastoma: few mutations, what else?

Buendia MA.

J Hepatol. 2014 Dec;61(6):1202-4. doi: 10.1016/j.jhep.2014.09.016. Epub 2014 Sep 17. No abstract available.

PMID:
25239079
24.

Massive gene amplification drives paediatric hepatocellular carcinoma caused by bile salt export pump deficiency.

Iannelli F, Collino A, Sinha S, Radaelli E, Nicoli P, D'Antiga L, Sonzogni A, Faivre J, Buendia MA, Sturm E, Thompson RJ, Knisely AS, Natoli G, Ghisletti S, Ciccarelli FD.

Nat Commun. 2014 May 13;5:3850. doi: 10.1038/ncomms4850. Erratum in: Nat Commun. 2015;6:7456.

PMID:
24819516
25.

[Bilateral endogenous ophthalmitis due to Candida glabrata after complicated bariatric surgery].

Pizango O, Tejeda E, Buendia M, Lujan S.

Arch Soc Esp Oftalmol. 2014 Jul;89(7):282-5. doi: 10.1016/j.oftal.2013.12.009. Epub 2014 Jan 30. Spanish.

PMID:
24485524
26.

Blood amyloid beta levels in healthy, mild cognitive impairment and Alzheimer's disease individuals: replication of diastolic blood pressure correlations and analysis of critical covariates.

Ruiz A, Pesini P, Espinosa A, Pérez-Grijalba V, Valero S, Sotolongo-Grau O, Alegret M, Monleón I, Lafuente A, Buendía M, Ibarria M, Ruiz S, Hernández I, San José I, Tárraga L, Boada M, Sarasa M.

PLoS One. 2013 Nov 27;8(11):e81334. doi: 10.1371/journal.pone.0081334. eCollection 2013.

27.

Long-term outcome of abdominal aortic aneurysm repair via a retroperitoneal approach.

Buendia MA, Santana O, Conde CA, Pineda AM, Zamora C, Lamas GA, Sivina M.

J Cardiovasc Surg (Torino). 2016 Aug;57(4):498-502. Epub 2013 Oct 9.

PMID:
24104586
28.

Methylphenidate place conditioning in adolescent rats: an analysis of sex differences and the dopamine transporter.

Cummins ED, Griffin SB, Burgess KC, Peterson DJ, Watson BD, Buendia MA, Stanwood GD, Brown RW.

Behav Brain Res. 2013 Nov 15;257:215-23. doi: 10.1016/j.bbr.2013.09.036. Epub 2013 Sep 29.

PMID:
24084582
29.

The oncogenic role of hepatitis B virus.

Rivière L, Ducroux A, Buendia MA.

Recent Results Cancer Res. 2014;193:59-74. doi: 10.1007/978-3-642-38965-8_4. Review.

PMID:
24008293
30.

Course of COPD assessment test (CAT) and clinical COPD questionnaire (CCQ) scores during recovery from exacerbations of chronic obstructive pulmonary disease.

Miravitlles M, García-Sidro P, Fernández-Nistal A, Buendía MJ, Espinosa de los Monteros MJ, Molina J.

Health Qual Life Outcomes. 2013 Aug 29;11:147. doi: 10.1186/1477-7525-11-147.

31.

LIM-only protein FHL2 activates NF-κB signaling in the control of liver regeneration and hepatocarcinogenesis.

Dahan J, Nouët Y, Jouvion G, Levillayer F, Adib-Conquy M, Cassard-Doulcier AM, Tebbi A, Blanc F, Remy L, Chen J, Cairo S, Werts C, Si-Tahar M, Tordjmann T, Buendia MA, Wei Y.

Mol Cell Biol. 2013 Aug;33(16):3299-308. doi: 10.1128/MCB.00105-13. Epub 2013 Jun 17.

32.

Methyltransferase PRMT1 is a binding partner of HBx and a negative regulator of hepatitis B virus transcription.

Benhenda S, Ducroux A, Rivière L, Sobhian B, Ward MD, Dion S, Hantz O, Protzer U, Michel ML, Benkirane M, Semmes OJ, Buendia MA, Neuveut C.

J Virol. 2013 Apr;87(8):4360-71. doi: 10.1128/JVI.02574-12. Epub 2013 Feb 6.

33.

The four and a half LIM-only protein 2 (FHL2) activates transforming growth factor β (TGF-β) signaling by regulating ubiquitination of the E3 ligase Arkadia.

Xia T, Lévy L, Levillayer F, Jia B, Li G, Neuveut C, Buendia MA, Lan K, Wei Y.

J Biol Chem. 2013 Jan 18;288(3):1785-94. doi: 10.1074/jbc.M112.439760. Epub 2012 Dec 4.

34.

The four and a half LIM-only protein 2 regulates liver homeostasis and contributes to carcinogenesis.

Nouët Y, Dahan J, Labalette C, Levillayer F, Julien B, Jouvion G, Cairo S, Vives FL, Ribeiro A, Huerre M, Colnot S, Perret C, Nhieu JT, Tordjmann T, Buendia MA, Wei Y.

J Hepatol. 2012 Nov;57(5):1029-36. doi: 10.1016/j.jhep.2012.06.035. Epub 2012 Jul 11.

PMID:
22796152
35.

Diverse roles of hepatitis B virus in liver cancer.

Fallot G, Neuveut C, Buendia MA.

Curr Opin Virol. 2012 Aug;2(4):467-73. doi: 10.1016/j.coviro.2012.05.008. Epub 2012 Jun 19. Review.

PMID:
22722078
36.

How transient becomes stable: an epigenetic switch linking liver inflammation and tumorigenesis.

Cairo S, Buendia MA.

J Hepatol. 2012 Oct;57(4):910-2. doi: 10.1016/j.jhep.2012.05.017. Epub 2012 Jun 2. No abstract available.

37.

Haploinsufficiency of the E3 ubiquitin ligase C-terminus of heat shock cognate 70 interacting protein (CHIP) produces specific behavioral impairments.

McLaughlin B, Buendia MA, Saborido TP, Palubinsky AM, Stankowski JN, Stanwood GD.

PLoS One. 2012;7(5):e36340. doi: 10.1371/journal.pone.0036340. Epub 2012 May 11.

38.

Subset of Suz12/PRC2 target genes is activated during hepatitis B virus replication and liver carcinogenesis associated with HBV X protein.

Studach LL, Menne S, Cairo S, Buendia MA, Hullinger RL, Lefrançois L, Merle P, Andrisani OM.

Hepatology. 2012 Oct;56(4):1240-51. doi: 10.1002/hep.25781.

39.

Inhibition of PP1 phosphatase activity by HBx: a mechanism for the activation of hepatitis B virus transcription.

Cougot D, Allemand E, Rivière L, Benhenda S, Duroure K, Levillayer F, Muchardt C, Buendia MA, Neuveut C.

Sci Signal. 2012 Jan 3;5(205):ra1. doi: 10.1126/scisignal.2001906.

40.

Activation of Wnt and Myc signaling in hepatoblastoma.

Cairo S, Armengol C, Buendia MA.

Front Biosci (Elite Ed). 2012 Jan 1;4:480-6. Review.

PMID:
22201888
41.

Myc target miRs and liver cancer: small molecules to get Myc sick.

Buendia MA, Bourre L, Cairo S.

Gastroenterology. 2012 Feb;142(2):214-8. doi: 10.1053/j.gastro.2011.12.023. Epub 2011 Dec 16. Review. No abstract available.

PMID:
22178210
42.

Over-expression of SERPINB3 in hepatoblastoma: a possible insight into the genesis of this tumour?

Turato C, Buendia MA, Fabre M, Redon MJ, Branchereau S, Quarta S, Ruvoletto M, Perilongo G, Grotzer MA, Gatta A, Pontisso P.

Eur J Cancer. 2012 May;48(8):1219-26. doi: 10.1016/j.ejca.2011.06.004. Epub 2011 Jul 5.

PMID:
21737255
43.

Outcomes of minimally invasive valve surgery versus standard sternotomy in obese patients undergoing isolated valve surgery.

Santana O, Reyna J, Grana R, Buendia M, Lamas GA, Lamelas J.

Ann Thorac Surg. 2011 Feb;91(2):406-10. doi: 10.1016/j.athoracsur.2010.09.039.

PMID:
21256280
44.

Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer.

Cairo S, Wang Y, de Reyniès A, Duroure K, Dahan J, Redon MJ, Fabre M, McClelland M, Wang XW, Croce CM, Buendia MA.

Proc Natl Acad Sci U S A. 2010 Nov 23;107(47):20471-6. doi: 10.1073/pnas.1009009107. Epub 2010 Nov 8.

45.

Molecular biology of the hepatitis B virus and role of the X gene.

Wei Y, Neuveut C, Tiollais P, Buendia MA.

Pathol Biol (Paris). 2010 Aug;58(4):267-72. doi: 10.1016/j.patbio.2010.03.005. Epub 2010 May 18. Review.

PMID:
20483545
46.

TAK1 suppresses a NEMO-dependent but NF-kappaB-independent pathway to liver cancer.

Bettermann K, Vucur M, Haybaeck J, Koppe C, Janssen J, Heymann F, Weber A, Weiskirchen R, Liedtke C, Gassler N, Müller M, de Vos R, Wolf MJ, Boege Y, Seleznik GM, Zeller N, Erny D, Fuchs T, Zoller S, Cairo S, Buendia MA, Prinz M, Akira S, Tacke F, Heikenwalder M, Trautwein C, Luedde T.

Cancer Cell. 2010 May 18;17(5):481-96. doi: 10.1016/j.ccr.2010.03.021.

47.

Deficiency of the LIM-only protein FHL2 reduces intestinal tumorigenesis in Apc mutant mice.

Labalette C, Nouët Y, Levillayer F, Colnot S, Chen J, Claude V, Huerre M, Perret C, Buendia MA, Wei Y.

PLoS One. 2010 Apr 28;5(4):e10371. doi: 10.1371/journal.pone.0010371.

48.

Reprogramming of miRNA networks in cancer and leukemia.

Volinia S, Galasso M, Costinean S, Tagliavini L, Gamberoni G, Drusco A, Marchesini J, Mascellani N, Sana ME, Abu Jarour R, Desponts C, Teitell M, Baffa R, Aqeilan R, Iorio MV, Taccioli C, Garzon R, Di Leva G, Fabbri M, Catozzi M, Previati M, Ambs S, Palumbo T, Garofalo M, Veronese A, Bottoni A, Gasparini P, Harris CC, Visone R, Pekarsky Y, de la Chapelle A, Bloomston M, Dillhoff M, Rassenti LZ, Kipps TJ, Huebner K, Pichiorri F, Lenze D, Cairo S, Buendia MA, Pineau P, Dejean A, Zanesi N, Rossi S, Calin GA, Liu CG, Palatini J, Negrini M, Vecchione A, Rosenberg A, Croce CM.

Genome Res. 2010 May;20(5):589-99. doi: 10.1101/gr.098046.109.

49.

Mechanisms of HBV-related hepatocarcinogenesis.

Neuveut C, Wei Y, Buendia MA.

J Hepatol. 2010 Apr;52(4):594-604. doi: 10.1016/j.jhep.2009.10.033. Epub 2010 Jan 7. Review.

50.

Liver cell transformation in chronic HBV infection.

Benhenda S, Cougot D, Neuveut C, Buendia MA.

Viruses. 2009 Dec;1(3):630-46. doi: 10.3390/v1030630. Epub 2009 Oct 30.

Supplemental Content

Loading ...
Support Center